These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Clinical experience with mitomycin C (NSC-26980). Whittington RM; Close HP Cancer Chemother Rep; 1970 Jun; 54(3):195-8. PubMed ID: 4334088 [No Abstract] [Full Text] [Related]
10. Streptozocin: a review of its pharmacology, efficacy, and toxicity. Weiss RB Cancer Treat Rep; 1982 Mar; 66(3):427-38. PubMed ID: 6277485 [No Abstract] [Full Text] [Related]
11. Toxicology studies with mitomalcin (NSC-113233) in dogs. Morrison RK; Brown DE; Timmens EK; Nieglos MA; Cooney D Cancer Chemother Rep; 1970 Aug; 54(4):217-23. PubMed ID: 5527018 [No Abstract] [Full Text] [Related]
12. Pancreatic islet cell carcinoma in a dog treated with streptozotocin. Meyer DJ Am J Vet Res; 1976 Oct; 37(10):1221-3. PubMed ID: 185926 [TBL] [Abstract][Full Text] [Related]
13. "Big" insulin and the treatment of an islet cell carcinoma with streptozotocin. Pearson MJ; Larkins RG; Martin FI Metabolism; 1972 Jun; 21(6):551-8. PubMed ID: 4337586 [No Abstract] [Full Text] [Related]
14. Streptozotocin and metastatic insulinoma. Carter SK; Broder L; Friedman M Ann Intern Med; 1971 Mar; 74(3):445-6. PubMed ID: 4324025 [No Abstract] [Full Text] [Related]
15. Treatment of malignant insulinoma with Streptozotocin. Smith CK; Stoll RW; Vance J; Ricketts H; Williams RH Diabetologia; 1971 Apr; 7(2):118-24. PubMed ID: 4325749 [No Abstract] [Full Text] [Related]
16. The clinical effects of prolonged intravenous infusion of 5-fluoro-2'-deoxyuridine. Sullivan RD; Miller E Cancer Res; 1965 Aug; 25(7):1025-33. PubMed ID: 4284747 [No Abstract] [Full Text] [Related]